ExpressCells

About:

ExpressCells creates custom cell lines for biological research and drug discovery.

Top Investors: Rowan University, Tech Coast Angels, Berkeley Angel Network, Robin Hood Ventures, MIT Alumni Angels of Northern California

Description:

ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.

Total Funding Amount:

$1.79M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2018-01-01

Contact Email:

mhandel(AT)xpresscells.com

Founders:

Matthew Handel, Oscar Perez-Leal

Number of Employees:

1-10

Last Funding Date:

2020-10-23

IPO Status:

Private

Industries: